Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530497) titled 'Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures' on April 8.

Study Type: Observational

Primary Sponsor: SI-BONE, Inc.

Condition: Fracture Pelvic Insufficiency Fractures Fragility Fracture Sacroiliac Fusion Sacroiliac Joint Disruption Sacroiliac Joint Dysfunction

Intervention: Device: iFuse TORQ TNT Implant System

Recruitment Status: Not recruiting

Date of First Enrollment: August 2026

Target Sample Size: 120

To know more, visit https://clinicaltrials.gov/study/NCT07530497

Disclaimer: Curated by HT Syndication....